wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37896606-9F2D5E7B-AE17-4492-98BA-D038E49B974F
Q37896606-9F2D5E7B-AE17-4492-98BA-D038E49B974F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37896606-9F2D5E7B-AE17-4492-98BA-D038E49B974F
The current role of high-dose imatinib in chronic myeloid leukemia patients, newly diagnosed or resistant to standard dose.
P2860
Q37896606-9F2D5E7B-AE17-4492-98BA-D038E49B974F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37896606-9F2D5E7B-AE17-4492-98BA-D038E49B974F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cab0ac4f52422099415751828733c37dabbfe86e
P2860
Imatinib mesylate dose escalation is associated with durable responses in patients with chronic myeloid leukemia after cytogenetic failure on standard-dose imatinib therapy.